University of California, San Francisco, San Francisco, California (Alka M. Kanaya; Stephen Hulley, Eric Vittinghoff); Northwestern University, Chicago, Illinois (Namratha Kandula; Kiang Liu); Wake Forest University Medical Center, Winston-Salem, North Carolina (David Herrington); Harbor-University of California, Los Angeles, Torrance, California (Matthew J. Budoff).
Clin Cardiol. 2013 Dec;36(12):713-720. doi: 10.1002/clc.22219. Epub 2013 Nov 5.
South Asians (individuals from India, Pakistan, Bangladesh, Nepal, and Sri Lanka) have high rates of cardiovascular disease (CVD) that cannot be explained by traditional risk factors. There are few prospective cohort studies investigating antecedents of CVD in South Asians.
The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study is investigating the prevalence, correlates, and outcomes associated with subclinical CVD in a population-based sample of South Asian men and women age 40-79 years at 2 US clinical field centers.
This cohort is similar in methods and measures to the Multi-Ethnic Study of Atherosclerosis (MESA) to allow for efficient cross-ethnic comparisons. Measurements obtained at the baseline examination include sociodemographic information, lifestyle and psychosocial factors, standard CVD risk factors, oral glucose tolerance testing, electrocardiography, assessment of microalbuminuria, ankle and brachial blood pressures, carotid intima-media wall thickness using ultrasonography, coronary artery calcium measurement, and abdominal visceral fat measurement using computed tomography. Blood samples will be assayed for biochemical risk factors. Between October 2010 and March 2013, we enrolled 906 South Asians with mean age of 55 ± 9 years (46% women; 98% immigrants who have lived 27 ± 11 years in the United States). The sociodemographic characteristics of this cohort are representative of US South Asians. Participants are being followed with annual telephone calls for identification of CVD events including acute myocardial infarction and other coronary heart disease, stroke, peripheral vascular disease, congestive heart failure, therapeutic interventions for CVD, and mortality.
The MASALA study will provide novel data on the prevalence and associations of cardiovascular risk factors and subclinical atherosclerosis in South Asians living in the United States.
南亚人(来自印度、巴基斯坦、孟加拉国、尼泊尔和斯里兰卡的个体)患有心血管疾病(CVD)的比率很高,这不能用传统的危险因素来解释。目前,针对南亚人 CVD 发病前情况的前瞻性队列研究较少。
在美国生活的南亚动脉粥样硬化的介质(MASALA)研究正在调查一个基于人群的南亚男性和女性队列(年龄在 40-79 岁之间)的亚临床 CVD 的流行率、相关性和结局,该队列在 2 个美国临床现场中心进行。
该队列在方法和测量上与动脉粥样硬化多民族研究(MESA)相似,以便能够进行有效的跨种族比较。基线检查中获得的测量包括社会人口统计学信息、生活方式和心理社会因素、标准 CVD 危险因素、口服葡萄糖耐量试验、心电图、微量白蛋白尿评估、踝臂血压、颈动脉内膜中层壁厚度超声检查、冠状动脉钙测量和腹部内脏脂肪使用计算机断层扫描进行测量。血液样本将用于生化危险因素的检测。在 2010 年 10 月至 2013 年 3 月期间,我们招募了 906 名南亚人,平均年龄为 55±9 岁(46%为女性;98%为移民,在美国生活了 27±11 年)。该队列的社会人口统计学特征代表了美国南亚人。通过每年的电话随访来追踪参与者,以确定 CVD 事件,包括急性心肌梗死和其他冠心病、中风、外周血管疾病、充血性心力衰竭、CVD 的治疗干预和死亡率。
MASALA 研究将提供有关在美国生活的南亚人心血管危险因素和亚临床动脉粥样硬化的患病率和相关性的新数据。